Skip to Main Content

Paper Details

Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
47
2016
CRC, Colorectal Cancer, Crohn's disease, IBD, IBDs, Inflammatory Bowel Diseases, Inflammatory bowel diseases, Patients, Statin, Statins, colorectal cancer, patients, primary sclerosing cholangitis, sporadic CRC, statin, statins, ulcerative colitis
Author NameAffiliation
Ashwin N AnanthakrishnanMassachusetts General Hospital, Massachusetts Harvard Medical School
Tianxi CaiHarvard T.H. Chan School of Public Health
Tianxi CaiHarvard T.H. Chan School of Public Health
Vivian S Gainer
Susanne ChurchillHarvard Medical School
Susanne ChurchillHarvard Medical School
Elizabeth W KarlsonHarvard Medical School, Brigham and Women's Hospital
Elizabeth W KarlsonHarvard Medical School, Brigham and Women's Hospital
Shawn N MurphyHarvard Medical School, Massachusetts General Hospital
Shawn N MurphyHarvard Medical School, Massachusetts General Hospital
Katherine P LiaoHarvard Medical School, Brigham and Women's Hospital
Isaac S KohaneHarvard Medical School, Massachusetts Children's Hospital Boston
Isaac S KohaneHarvard Medical School, Massachusetts Children's Hospital Boston
  • 1 - 13

Datasets